First Time Use of SD-809 in Huntington Disease

NCT01795859 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Chorea

Interventions

DRUG: SD-809
DRUG: Placebo

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.